Collectively, these findings suggest that the bioactive compounds of turmeric, in particular curcumin, can be promising dietary pancreatic lipase inhibitors for the prevention and management of obesity. Here, PNLIP is linked to obesity due to melanocortin 4 receptor deficiency.